Skip to main content
Premium Trial:

Request an Annual Quote

Alveo Technologies: Neil Gunn

Alveo has appointed Neil Gunn to its board of directors. Gunn is currently the CEO of IDbyDNA after recently retiring as president of Roche Sequencing Solutions. He will advise on overall business plans for Alveo's be.well at-home infectious disease testing platform.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.